Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Immunology|July 22, 2020
Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancerEce Tavukcuoglu, Utku Horzum, Hamdullah Yanik, et al.
Cell Death and Differentiation|March 2, 2023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplificationOzge Saatci, Ozge Akbulut, Metin Cetin, et al.
Nature Communications|November 2, 2023
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancerOzge Saatci, Metin Cetin, Meral Uner, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 8, 2015
Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromesOzlen Bektas, Aysegul Uner, Yahya Buyukasik, et al.
International Journal of Hematology|May 27, 2015
High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiologyOzlen Bektas, Aysegul Uner, Seda Muruvvet Aydin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 30, 2025
Immune Checkpoint Molecule Expression, 9p24.1 Gene Alterations, and Tumor Microenvironment of Primary Central Nervous System Lymphomas and Their Clinical RelevanceDilara Akbulut, Seher Yuksel, Ekin Kircali, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 19, 2021
Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the LiteratureDeniz Cagdas, Sevil Oskay Halacli, Cagman Tan, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Targeting LINC00152 activates cAMP/Ca<sup>2+</sup>/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancerOzge Saatci, Rashed Alam, Kim-Tuyen Huynh-Dam, et al.
Cell Death & Disease|June 15, 2024
Targeting LINC00152 activates cAMP/Ca<sup>2+</sup>/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancerOzge Saatci, Rashedul Alam, Kim-Tuyen Huynh-Dam, et al.
Pageof 6